Address

11.2 Capital
San Francisco, CA
United States

Open map


Recent investment activity

Tags
KANDO id: 581876

Corporate information

Founders
Registration country

Overview

11.2 Capital is an early stage venture capital fund based in San Francisco, investing in breakthrough technology in artificial intelligence, AR/VR, robotics, space, and data-driven health. 11.2 Capital is an investor in Bay Labs, Auransa, Deep Genomics, Loop Genomics, Genturi, Molecular Assemblies, Notable Labs, Diassess, Hinge Health, and Ginkgo Bioworks.



Funding rounds

Top investment portfolio themes


Investment activity status
Active investor

Selected investments

Displaying 1 - 16 of 16
Profile Country Date Funding
Anyscale Series A Initial investment
CryptoNumerics Inc CryptoNumerics helps organizations to use data to gain insights while overcoming privacy and data residency issues. Seed led the round
Deep Genomics Inc Seed
Elucidate GmbH Seed Initial investment led the round
Hinge Health Inc Seed Initial investment led the round
Hinge Health Inc Series A Follow-on investment
Hinge Health Inc Series C Follow-on investment
Kindred Systems Inc Developer of machines with human-like intelligence. Series A
Mantle Venture Initial investment
Notable Labs Inc N/A Initial investment
Orbital Sidekick Series A Initial investment
Outlier AI Inc Series A Initial investment
Outlier AI Inc Series B Follow-on investment
SardineAI Corp (Sardine AI) Seed Initial investment
TigerGraph TigerGraph has built the world's first, and fastest, real-time graph database and analytics platform. Seed Initial investment
Umedeor Ltd N/A Initial investment

Current employees

Employee Position
Shelley Zhuang photo Shelley Zhuang (founder)
[node:title] photo David Dorsey
[node:title] photo Pramod Gosavi
[node:title] photo Jacob Smith